Alternative and Synergistic Strategies Against Antibiotic-Resistant Staphylococcus aureus in Clinical and Environmental Settings.

Authors

Kiandokht Babolhavaeji, Sima Kazemi, Tahere Etesamifard, Rahmat Solgi

Published in

International journal of microbiology. Volume 2026. Pages 8281541. Epub Oct 16, 2026.

Abstract

Antimicrobial resistance (AMR) in Staphylococcus aureus (S. aureus) poses a serious global health threat, undermining treatment outcomes and necessitating the development of innovative therapeutic strategies. Methicillin-resistant Staphylococcus aureus (MRSA) is a major contributor to this burden, with increasing prevalence in hospitals, contaminated food, and environmental sources. The coronavirus disease 2019 (COVID-19) pandemic further intensified S. aureus resistance due to widespread antibiotic misuse. Biofilm formation, which facilitates the horizontal transfer of resistance genes such as mecA (methicillin resistance gene A), plays a central role in the development of resistance. To counteract antibiotic-resistant S. aureus, alternative approaches have emerged, including antimicrobial peptides (AMPs), photodynamic therapy (PDT), and drug repurposing guided by artificial intelligence (AI). Cutting-edge technologies such as clustered regularly interspaced short palindromic repeats (CRISPR)-CRISPR-associated protein 13a (Cas13a)-based gene editing and engineered bacteriophages offer promising avenues for targeting resistant strains. Natural compounds such as thymol and chlorogenic acid (CGA) have also shown potential in reducing resistance and inhibiting biofilm formation. Effective management of AMR requires strengthened antibiotic stewardship programs (ASPs), robust surveillance systems, and public health measures such as proper hand hygiene and environmental sanitation. Combining antibiotic adjuvants (AAs) with existing antibiotics and leveraging bioactive peptides (BAPs) can enhance antibiotic efficacy against multidrug-resistant (MDR), extensively drug-resistant (XDR), and pan-drug-resistant (PDR) S. aureus. This review investigates the prevalence and resistance mechanisms of S. aureus in clinical, food, and environmental contexts, explores promising alternative therapies, and emphasizes the urgent need for global antimicrobial stewardship (AMS) and sustainable intervention strategies.

PMID:
42891379
Bibliographic data and abstract were imported from PubMed on 18 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.